Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain

Neuropharmacology

Volumn 38, Issue 7, 1999, Pages 1063-1073

  Zetterstrom T S C ^a   Pei, Q ^a   Madhav, T R ^a   Coppell, A L ^a   Lewis, L ^a   Grahame Smith, D G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

5 HT; Brain derived neurotrophic factor; Dentate gyrus; Immunocytochemistry; In situ hybridization; Rat brain

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHLORAMPHETAMINE; FENCLONINE; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; FRONTAL CORTEX; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; FENCLONINE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN; SEROTONIN ANTAGONISTS; TISSUE DISTRIBUTION;

EID: 0033046376     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00022-2     Document Type: Article

References (38)

1. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neur. 179:1978;641-668.
2. Celada P., Siuciak J.A., Tran T.M., Altar C.A., Tepper J.M. Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphe' serotonergic neurons. Brain. Res. 712:1996;293-298.
3. Chen L., Hamaguchi K., Ogawa M., Hamada S., Okado N. PCPA reduces both monoaminergic afferents and nonmonoaminergic synapses in the cerebral cortex. Neurosci. Res. 19:1994;111-115.
4. Condorelli D.F., Dell'Albani P., Mudo G., Timmusk T., Belluardo N. Expression of neurotrophins and their receptors in primary astroglial cultures: induction by cyclic AMP-elevating agents. J. Neurochem. 63:1994;509-516.
5. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17:1997;2295-2313.
6. Freund T.F., Gulyas A., Acsady L., Gores T., Toth K. Serotonergic control of the hippocampus via local inhibitory interneurons. Proc. Natl. Acad. Sci. USA. 87:1990;8501-8505.
7. Grahame-Smith D.G. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J. Neurochem. 18:1971;1053-1066.
8. Ghosh A., Carnahan J., Greenberg M.E. Requirement for BDNF in activity-dependent survival of cortical neurons. Science. 263:1994;1618-1623.
9. Green A.R., Grahame-Smith D.G. Effects of drugs on the process regulating the functional activity of brain 5-hydroxytryptamine. Nature. 260:1976;487-491.
10. Humpel C., Wetmore C., Olson L. Regulation of brain-derived neurotropic factor messenger RNA and protein at the cellular level in pentylenetetrazol-induced epileptic seizures. Neuroscience. 53:1993;909-918.
11. Koe B.K., Weissman A. p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmac. Exp. Ther. 154:1966;499-516.
12. Lewin G.R., Barde Y.-A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
13. Lindefors N., Brodin E., Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trk B messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience. 65:1995;661-670.
14. Lidov H.G.W., Girzanna R., Molliver M.E. The serotonin innervation of the cerebral cortex: an immunohistochemical analysis. Neuroscience. 5:1980;207-227.
15. Mamounas L.A., Mullen C.A., O'Hearn E., Molliver M.E. Dual serotoninergic projections to the forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit different vulnerability to neurotoxic amphetamine derivates. J. Comp. Neurol. 314:1991;558-586.
16. Mamounas L.A., Blue M.E., Siuciak J.A., Altar C.A. BDNF promotes the survival and sprouting of serotonergic axons in the rat brain. J. Neurosci. 15:1995;7929-7939.
17. Marek G.J., Aghajanian G.K. Excitation of interneurons in piriform cortex by 5-hydroxytryptamine; blockade by MDL 100 907, a highly selective 5-HT2 receptor antagonist. Eur. J. Pharmacol. 259:1994;137-141.
18. Martin-Iverson M.T., Todd K.G., Altar A.C. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonone metabolism and related behaviours; interactions with amphetamine. J. Neurosci. 14:1994;1262-1270.
19. Millicent M., Dugich-Djordjevic M.M., Peterson C., Isono F., Ohsawa F., Widmer H.R., Dento T.L., Bennett G.L., Hefti F. Immunohistochemical visualization of brain-derived neurotrophic factor in the rat brain. Eur. J. Neurosci. 7:1995;1831-1839.
20. Moorman J.M., Jackson A., Grahame-Smith D.G., Leslie R.A. Induction of c-fos in rat forebrain by pharmacological manipulations of 5-hydroxytryptamine levels. Neuroscience. 68:1995;1089-1096.
21. Neeper S.A., Gomez-Pinilla F., Choi J., Cotman C.W. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain. Res. 726:1996;49-56.
22. Nawa H., Pelleymounter M.A., Carnahan J. Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J. Neurosci. 14:1994;3751-3765.
23. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trk B mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatment. J. Neurosci. 15:1995;7539-7547.
24. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16:1996;2365-2372.
25. Pei Q., Burnet P.W.J., Grahame-Smith D.G., Zetterström T.S.C. Differential effects of acute and chronic electroconvulsive shock on the abundance of messenger RNAs for voltage-dependent potassium channel subunits in the rat brain. Neuroscience. 78:1997;343-350.
26. Schmidt-Kastner R., Wetmore C., Olson L. Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, striatum and cortex. Neuroscience. 74:1996;161-183.
27. Series H.G., Molliver M.E. Immunocytochemical evidence for serotonergic neurotoxicity of N-ethyl-methylenedioxyamphetamine (MDE). Exp. Mol. Neurol. 128:1994;50-58.
28. Sharp T. Biochemical measurement of serotonergic neurotransmission in vivo: effect of antidepressant and anxiolytic treatments. Elliott J.M., Heal J., Marsden C.A. Experimental Approaches to Anxiety and Depression. 1992;117-149 J. Wiley, Chichester.
29. Sharp T., Umbers V., Gartside S.E. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br. J. Pharmacol. 121:1997;941-946.
30. Sleight A.J., Marsden C.A., Sharp T. Elliott J.M., Heal D.J., Marsden C.A. Experimental Approaches to Anxiety and Depression. 1992;117-149 Biddles, Great Britain.
31. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15:1995;1768-1777.
32. Smith M.A., Zhang L., Lyons W.E., Mamounas L.A. Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. Neuroreport. 8:1997;1829-1834.
33. Siuciak J.A., Boylan C., Fritsche M., Altar C.A., Lindsay R.M. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res. 710:1996;11-20.
34. Vaidya V.A., Marek G.J., Aghajanian G.K., Duman R.S. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 17(8):1997;2785-2795.
35. Wetmore C., Olson L., Bean A.J. Regulation of brain-derived neurotrophic factor (BDNF) expression and release from hippocampal neurons is mediated by non-NMDA type glutamate receptors. J. Neurosci. 14:1994;1688-1700.
36. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., Jennes L. Comparative localization of serotonin 1A, 1C and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 351:1995;357-373.
37. Zetterström T.S.C., Pei Q., Grahame-Smith D.G. Repeated electroconvulsive shock extends the duration of enhanced gene expression for BDNF in rat brain compared with a single administration. Mol. Brain. Res. 57:1998;106-110.
38. Zetterström T.S.C., Pei Q., Ainsworth K., Grahame-Smith D.G. Effects of antidepressant treatments on BDNF gene expression in rat brain. Br. J. Pharmacol. 123:1998;211P.